Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cristescu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oftalmologia (Bucharest, Romania : 1990)|February 22, 2013
[Penetrating ocular trauma with intraocular foreign body--surgical resolution]Ovidiu Musat, Corina Coman, Uliana Ochinciuc, et al.
Animal Microbiome|February 1, 2022
How microbiomes can help inform conservation: landscape characterisation of gut microbiota helps shed light on additional population structure in a specialist folivoreB L Littleford-Colquhoun, L S Weyrich, K Hohwieler, et al.
Nederlands Tijdschrift Voor Tandheelkunde|July 27, 2015
[Endodontics in motion: new concepts, materials and techniques 1. Hydraulic Calcium Silicate Cements]A T Moinzadeh, L Jongsma, D de Groot-Kuin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumabD Fabrizio, R Cristescu, L Albacker, et al.
Molecular Ecology|February 9, 2023
Evaluating the genetic consequences of population subdivision as it unfolds and how to best mitigate them: A rare story about koalasC H Frère, G D O'Reilly, K Strickland, et al.
Biofabrication|March 24, 2015
Fabrication of magnetite-based core-shell coated nanoparticles with antibacterial propertiesA M Grumezescu, R Cristescu, M C Chifiriuc, et al.
Biofabrication|December 21, 2012
Functionalized magnetite silica thin films fabricated by MAPLE with antibiofilm propertiesD E Mihaiescu, R Cristescu, G Dorcioman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLCT S K Mok, G Lopes, B C Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2024
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaR J Motzer, C Porta, M Eto, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oftalmologia (Bucharest, Romania : 1990)|February 22, 2013
[Penetrating ocular trauma with intraocular foreign body--surgical resolution]Ovidiu Musat, Corina Coman, Uliana Ochinciuc, et al.
Animal Microbiome|February 1, 2022
How microbiomes can help inform conservation: landscape characterisation of gut microbiota helps shed light on additional population structure in a specialist folivoreB L Littleford-Colquhoun, L S Weyrich, K Hohwieler, et al.
Nederlands Tijdschrift Voor Tandheelkunde|July 27, 2015
[Endodontics in motion: new concepts, materials and techniques 1. Hydraulic Calcium Silicate Cements]A T Moinzadeh, L Jongsma, D de Groot-Kuin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumabD Fabrizio, R Cristescu, L Albacker, et al.
Molecular Ecology|February 9, 2023
Evaluating the genetic consequences of population subdivision as it unfolds and how to best mitigate them: A rare story about koalasC H Frère, G D O'Reilly, K Strickland, et al.
Biofabrication|March 24, 2015
Fabrication of magnetite-based core-shell coated nanoparticles with antibacterial propertiesA M Grumezescu, R Cristescu, M C Chifiriuc, et al.
Biofabrication|December 21, 2012
Functionalized magnetite silica thin films fabricated by MAPLE with antibiofilm propertiesD E Mihaiescu, R Cristescu, G Dorcioman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLCT S K Mok, G Lopes, B C Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2024
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaR J Motzer, C Porta, M Eto, et al.
Pageof 2